Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion

The visual and anatomic improvements after fixed dosing through week 24 and PRN dosing with monthly monitoring from weeks 24 to 52 were diminished after continued PRN dosing, with a reduced monitoring frequency from weeks 52 to 100.